Prolonged Daily Temozolomide for Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
- Status
- COMPLETED
- Phase
- PHASE3
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
- Status
- COMPLETED
- Phase
- PHASE2